Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Savannah
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Savannah, GA

Studies commonly pay $75 to $4,500 per completed study

169 clinical trials are currently recruiting participants within 30 miles of Savannah. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

169studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Savannah right now

Top 25 of 169 recruiting studies, sorted by proximity — each links to its official registry page

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Gynecologic Oncology and Surgical Specialists at the Lewis Cancer & Research Pavilion — Savannah, Georgia (6.1 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

COVID-19 Infection Phase 3 Interventional 300 participants sought
Velocity Clinical Research, Savannah — Savannah, Georgia (6.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07013474)

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Non-Small Cell Lung Cancer Phase 3 Interventional 272 participants sought
Curtis and Elizabeth Anderson Cancer — Savannah, Georgia (6.1 mi) · Sponsor: University of Texas Southwestern Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT02468024)

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Phase 4 Interventional 55 participants sought
Willett Children's Hospital at Memorial University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: American Thrombosis and Hemostasis Network
See eligibility & contact on ClinicalTrials.gov (NCT04647227)

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

Prostate Cancer Screening N/A Interventional 200 participants sought
Novant Health Coastal Carolina Medical Center — Hardeeville, South Carolina (18.8 mi) · Sponsor: Uro-1 Medical
See eligibility & contact on ClinicalTrials.gov (NCT06830265)

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

Atopic Dermatitis Phase 2 Interventional 160 participants sought
Atd002 52015 — Savannah, Georgia (6.1 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT07277660)

Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder

Cannabis Withdrawal Phase 3 Interventional 420 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi) · Sponsor: PleoPharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07644052)

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic, Cancer N/A Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Savannah, Georgia (6.1 mi) · Sponsor: Massive Bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03452774)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: PedAL BCU, LLC
See eligibility & contact on ClinicalTrials.gov (NCT04726241)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD (Chronic Obstructive Pulmonary Disease) Phase 3 Interventional 5,000 participants sought
Research Site — Savannah, Georgia (6.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06283966)

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids, Endometriosis Phase 3 Interventional 1,000 participants sought
Bluffton — Bluffton, South Carolina (23.7 mi) · Sponsor: Sumitomo Pharma Switzerland GmbH
See eligibility & contact on ClinicalTrials.gov (NCT05862272)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
Javara-Savannah-67450 — Savannah, Georgia (6.1 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Savannah, Georgia (6.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 195 participants sought
Privia Medical Group of Georgia, LLC — Savannah, Georgia (6.1 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight Phase 3 Interventional 12,800 participants sought
Velocity Clinical Research - Savannah — Savannah, Georgia (6.1 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07037433)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03418961)
Actively enrolling

Studies you may be able to join near Savannah

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Savannah

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Velocity Clinical Research

★ 4.8
340 Eisenhower Dr Ste 1500, Savannah, GA 31406
(912) 443-4253
"There wasn't anything that I had to do except report if I had any flu findings."
— Sylvia Oliver, 5★

CenExel Savannah GA

★ 5.0
6349 Abercorn St, Savannah, GA 31405
(912) 744-0800
"Great place. Friendly and professional!"
— scott parker, 5★

Iresearch Savannah

6349 Abercorn St, Savannah, GA 31405

Fellows Research Alliance Inc

★ 5.0
1 Oglethorpe Professional Blvd Ste 204, Savannah, GA 31406
(912) 355-4447
"Extremely professional and knowledgeable."
— Angela Williams, 5★

Velocity Clinical Research

230 E Derenne Ave, Savannah, GA 31405
(912) 790-4036

Nancy N. and J.C Lewis Cancer & Research Pavilion

★ 4.8 (1164 reviews)
225 Candler Dr, Savannah, GA 31405
(912) 819-5704
"Caring and kind professionals dispensing intravenous chemical cocktails to those of us that require it with a smile and kind inspiration. These hardw…"
— DEBRA GOLDBERG, 5★

SouthCoast Health Savannah Campus Building 1

★ 4.9
1326 Eisenhower Dr, Savannah, GA 31406
(912) 691-4100

SouthCoast Health Savannah Campus Building 2

★ 4.9
1326 Eisenhower Dr Bldg 2, Savannah, GA 31406
(912) 691-3600
"Dr. Bhavesh Patel was kind, professional, and took the time to listen to my concerns. He explained everything clearly and made me feel comfortable th…"
— Rahee, 5★

ExperCARE Urgent Care & Primary Care

★ 4.7
318 Mall Blvd Suite 300B, Savannah, GA 31406
(912) 358-1515
"They were quick to see me, kind with good customer service, courteous, and listened to and addressed all my concerns. They made sure to check and per…"
— Soul Q Original, 5★

Clinical trials in Savannah: what's recruiting

The Savannah area currently has 169 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Savannah, the most active research areas are:

  • Cancer & Oncology13 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism3 studies
  • Brain & Mental Health2 studies
  • Liver & Kidney2 studies

Every listing shows the study phase, the recruiting site and its distance from Savannah, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Savannah

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Savannah participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Savannah pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Savannah?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Savannah safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Savannah, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Savannah?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Savannah

Other metros within reach

Charleston, SC731 Augusta, GA188 Jacksonville, FL916 Columbia, SC189 Warner Robins, GA77 Gainesville, FL538 Macon, GA77 Myrtle Beach, SC88

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Savannah Severe Chronic Pruritus in Savannah Chronic Kidney Disease (HealthMatch) in Savannah Bladder Issues Due To Spinal Cord Injury in Savannah All conditions

More of GA

Atlanta1,711 Augusta188 Gainesville154 Macon77 Warner Robins77 Athens75 Columbus71

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts